Anti-TSCOT/ SLC46A2/ Ly110 monoclonal antibody

Anti-TSCOT/ SLC46A2/ Ly110 antibody for FACS & in-vivo assay

Target products collectionGo to SLC46A2/SLC46A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1631-Ab-1/ GM-Tg-hg-MP1631-Ab-2Anti-Human SLC46A2 monoclonal antibodyHuman
GM-Tg-rg-MP1631-Ab-1/ GM-Tg-rg-MP1631-Ab-2Anti-Rat SLC46A2 monoclonal antibodyRat
GM-Tg-mg-MP1631-Ab-1/ GM-Tg-mg-MP1631-Ab-2Anti-Mouse SLC46A2 monoclonal antibodyMouse
GM-Tg-cynog-MP1631-Ab-1/ GM-Tg-cynog-MP1631-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC46A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1631-Ab-1/ GM-Tg-felg-MP1631-Ab-2Anti-Feline SLC46A2 monoclonal antibodyFeline
GM-Tg-cang-MP1631-Ab-1/ GM-Tg-cang-MP1631-Ab-2Anti-Canine SLC46A2 monoclonal antibodyCanine
GM-Tg-bovg-MP1631-Ab-1/ GM-Tg-bovg-MP1631-Ab-2Anti-Bovine SLC46A2 monoclonal antibodyBovine
GM-Tg-equg-MP1631-Ab-1/ GM-Tg-equg-MP1631-Ab-2Anti-Equine SLC46A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1631-Ab-1/ GM-Tg-hg-MP1631-Ab-2; GM-Tg-rg-MP1631-Ab-1/ GM-Tg-rg-MP1631-Ab-2;
GM-Tg-mg-MP1631-Ab-1/ GM-Tg-mg-MP1631-Ab-2; GM-Tg-cynog-MP1631-Ab-1/ GM-Tg-cynog-MP1631-Ab-2;
GM-Tg-felg-MP1631-Ab-1/ GM-Tg-felg-MP1631-Ab-2; GM-Tg-cang-MP1631-Ab-1/ GM-Tg-cang-MP1631-Ab-2;
GM-Tg-bovg-MP1631-Ab-1/ GM-Tg-bovg-MP1631-Ab-2; GM-Tg-equg-MP1631-Ab-1/ GM-Tg-equg-MP1631-Ab-2
Products NameAnti-SLC46A2 monoclonal antibody
Formatmab
Target NameSLC46A2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC46A2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TSCOT/ SLC46A2/ Ly110 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAP000254Human SLC46A2 Adenovirus plasmid
    ORF Viral VectorvGMAP000538Human SLC46A2 Adenovirus particle
    ORF Viral VectorpGMAP000538Human SLC46A2 Adenovirus plasmid
    ORF Viral VectorvGMAP000254Human SLC46A2 Adenovirus particle


    Target information

    Target IDGM-MP1631
    Target NameSLC46A2
    Gene ID57864,30936,298034,719542,403501,101080837,511556,100056842
    Gene Symbol and Synonyms5430429N04Rik,CE11,Ly110,SLC46A2,TSCOT,TSO-1C12
    Uniprot AccessionQ9BY10,Q866G7
    Uniprot Entry NameTSCOT_HUMAN,TSCOT_CANLF
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000119457
    Target ClassificationN/A

    The target: SLC46A2, gene name: SLC46A2, also named as Ly110, TSCOT. Predicted to enable transmembrane transporter activity. Involved in positive regulation of nucleotide-binding activity oligomerization domain containing 1 signaling pathway. Predicted to be located in cell surface and plasma membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.